इक्विटीम्यूचुअल फंड्स के लिए लोकप्रिय उपकरणों में से एक हैंनिवेश. यह मुख्य रूप से आपके पैसे को विभिन्न कंपनियों के शेयरों / शेयरों में निवेश करता है। फंड मैनेजर इन कंपनियों में फंड के निवेश उद्देश्य के आधार पर फंड आवंटित करता है। ये फंड उन निवेशकों के लिए आदर्श रूप से अनुकूल हैं जिनके पास मध्यम से उच्चजोखिम उठाने का माद्दा और लंबी अवधि की तलाश में हैंनिवेश योजना. लेकिन, जब एक आदर्श इक्विटी फंड चुनने की बात आती है तो यह एक मुश्किल काम हो सकता है। सैकड़ों इक्विटी म्यूचुअल फंड और प्रत्येक सर्वश्रेष्ठ रिटर्न का दावा करने के साथ, यह एक पर शून्य करने के लिए काफी उलझन में है। और कार्य तब कठिन हो जाते हैं जब आपको आगे अपने दम पर एक फंड चुनना होता है। आपके लिए प्रक्रिया को आसान और काफी सरल बनाने के लिए, हमने उन महत्वपूर्ण मापदंडों को सूचीबद्ध किया है जो आपको निवेश करने के लिए अच्छे फंडों को सूचीबद्ध करने में मदद करेंगे।
Talk to our investment specialist
आदर्श को चुनने के लिए गुणात्मक और मात्रात्मक उपाय निम्नलिखित हैं:इक्विटी फ़ंड.
म्यूचुअल फंड स्कीम के प्रदर्शन का श्रेय फंड मैनेजर के पास होता है। फंड के पोर्टफोलियो के लिए निवेश निर्णय लेने के लिए एक फंड मैनेजर जिम्मेदार होता है। इसलिए, निवेशकों को विशेष फंड मैनेजर द्वारा प्रबंधित फंड के प्रदर्शन के माध्यम से जाना चाहिए, खासकर कठिन समय के दौरानमंडी चरण साथ ही, निवेशकों को एक ऐसे फंड मैनेजर को अधिक प्राथमिकता देनी चाहिए, जिसके पास समान प्रकार के फंडों के प्रबंधन का अनुभव हो, उदाहरण के लिए- छोटे औरमध्यम दर्जे की कंपनियों के शेयर. एक ऐसे फंड मैनेजर के लिए जाना जो अपने करियर पर लगातार काम कर रहा हो, एक पसंदीदा विकल्प है।
का चयन करते समयसर्वश्रेष्ठ इक्विटी म्युचुअल फंड निवेश करने के लिए, हमेशा फंड हाउस की गुणवत्ता और प्रतिष्ठा को देखें। एक लंबे समय से रिकॉर्ड के साथ एक फंड हाउस, प्रबंधन के तहत बड़ी संपत्ति, स्टार फंड या अच्छा प्रदर्शन करने वाला फंड इत्यादि। आदर्श रूप से पसंद किया जाता है।
एकइन्वेस्टर समय की अवधि के लिए निधियों के प्रदर्शन का निष्पक्ष मूल्यांकन करना चाहिए। साथ ही, एक ऐसे फंड के लिए जाने का सुझाव दिया जाता है जो लगातार 4-5 वर्षों में अपने बेंचमार्क को पीछे छोड़ता है, साथ ही, प्रत्येक अवधि को देखना चाहिए और देखना चाहिए कि फंड बेंचमार्क को मात देने में सक्षम है या नहीं।
निवेशकों को हमेशा ऐसे फंड में जाना चाहिए जो न तो बहुत बड़ा हो और न ही बहुत छोटा हो। जबकि फंड के आकार के बीच कोई सटीक परिभाषा और संबंध नहीं है, यह कहा जाता है कि बहुत छोटा और बहुत बड़ा, दोनों ही फंड के प्रदर्शन में बाधा डाल सकते हैं। इस प्रकार, एक फंड चुनते समय, उसी के लिए जाने की सलाह दी जाती है जिसका एयूएम (एसेट अंडर मैनेजमेंट) लगभग श्रेणी के समान है।
जिन निवेशकों के पास म्यूच्यूअल फंड में निवेश है, उन्हें एसेट मैनेजमेंट कंपनी द्वारा लगाए गए कुछ शुल्क जैसे संचालन लागत, प्रबंधन शुल्क आदि का भुगतान करना पड़ता हैएएमसी) आम तौर पर, निष्क्रिय रूप से प्रबंधित योजनाओं की तुलना में सक्रिय रूप से प्रबंधित योजनाओं के लिए व्यय अनुपात अधिक होता है (जैसेइंडेक्स फंड्स याईटीएफ) के अनुसारसेबी नियम, इक्विटी फंड के लिए एक व्यय अनुपात न्यूनतम 2.5% है। हालांकि, व्यय अनुपात कुछ ऐसा है जो अन्य महत्वपूर्ण कारकों जैसे कि फंड प्रदर्शन आदि को प्रभावित नहीं करना चाहिए। यह जानते हुए कि फंड में उच्च व्यय अनुपात का भुगतान करना बेहतर है। प्रतिस्पर्धियों को अच्छे अंतर से मात देगी।
फंड के प्रदर्शन को मापने के लिए कुछ महत्वपूर्ण अनुपात हैं:
अल्फा-अल्फा यह आपके निवेश की सफलता या बेंचमार्क के मुकाबले बेहतर प्रदर्शन का एक पैमाना है। यह मापता है कि फंड या स्टॉक ने सामान्य बाजार में कितना प्रदर्शन किया है। 1 के सकारात्मक अल्फा का मतलब है कि फंड ने अपने बेंचमार्क इंडेक्स को 1% से बेहतर प्रदर्शन किया है, जबकि -1 का नकारात्मक अल्फा यह दर्शाता है कि फंड ने अपने बाजार बेंचमार्क की तुलना में 1% कम रिटर्न दिया है। इसलिए, मूल रूप से, एक निवेशक की रणनीति सकारात्मक अल्फा के साथ प्रतिभूतियों को खरीदने की होनी चाहिए।
बीटा- यह बेंचमार्क के सापेक्ष स्टॉक की कीमत या फंड में अस्थिरता को मापता है और इसे सकारात्मक या नकारात्मक आंकड़ों में दर्शाया जाता है। एबीटा 1 का मतलब है कि स्टॉक की कीमत बाजार के अनुरूप चलती है, 1 से अधिक का बीटा दर्शाता है कि स्टॉक बाजार की तुलना में जोखिम भरा है, और 1 से कम के बीटा का मतलब है कि स्टॉक बाजार की तुलना में कम जोखिम भरा है। इसलिए, गिरते बाजार में निचला बीटा बेहतर है। बढ़ते बाजार में, हाई-बीटा बेहतर है।
मानक विचलन (एसडी- सरल शब्दों में, एसडी एक सांख्यिकीय उपाय है जो किसी उपकरण में अस्थिरता या जोखिम का प्रतिनिधित्व करता है। एसडी जितना अधिक होगा, रिटर्न में उतार-चढ़ाव उतना ही अधिक होगा।
शार्प भाग-शार्प भाग लिए गए जोखिम के संबंध में रिटर्न (नकारात्मक और सकारात्मक दोनों) को मापता है। यहां जोखिम को मानक विचलन द्वारा परिभाषित किया गया है। ज्यादा शार्प रेशियो का मतलब है ज्यादा जोखिम के बिना ज्यादा रिटर्न। इस प्रकार, निवेश करते समय, निवेशकों को एक ऐसा फंड चुनना चाहिए जो उच्च शार्प अनुपात दिखाता हो।
सॉर्टिनो अनुपात- Theसॉर्टिनो अनुपात शार्प रेशियो का एक रूपांतर है। लेकिन, शार्प अनुपात के विपरीत, सॉर्टिनो अनुपात केवल नकारात्मक या नकारात्मक रिटर्न पर विचार करता है। इस तरह का अनुपात निवेशकों के लिए कुल अस्थिरता के प्रतिफल को देखने के बजाय बेहतर तरीके से जोखिम का आकलन करने में मददगार होता है। अपसाइड कैप्चर रेशियो और डाउनसाइड कैप्चर रेशियो- अपसाइड/डाउनसाइड कैप्चर रेशियो एक निवेशक का मार्गदर्शन करता है- चाहे कोई फंड बेहतर प्रदर्शन कर रहा हो या व्यापक मार्केट बेंचमार्क से कम प्राप्त हुआ हो या कम हुआ हो- मार्केट अपसाइड (मजबूत) या डाउनसाइड (कमजोर) के चरण के दौरान। और इससे भी महत्वपूर्ण बात यह है कि कितना। खैर, 100 से अधिक के अपसाइड रेशियो का मतलब है कि किसी दिए गए फंड ने सकारात्मक रिटर्न की अवधि के दौरान बेंचमार्क को पीछे छोड़ दिया है। और 100 से कम का नकारात्मक अनुपात दर्शाता है कि सुस्त रिटर्न के चरण के दौरान किसी दिए गए फंड ने अपने बेंचमार्क से कम खो दिया है। इसलिए, आम तौर पर, निवेशकों को ऐसे फंड के लिए जाना चाहिए जिसमें कम डाउनसाइड कैप्चर अनुपात और उच्च अपसाइड कैप्चर अनुपात हो।
उपरोक्त मापदंडों को ध्यान में रखते हुए, हमने 2022 में निवेश करने के लिए कुछ बेहतरीन इक्विटी फंडों को चुना है।
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2025 (%) DSP World Gold Fund Growth ₹47.8163
↓ -0.93 ₹1,442 -23.6 -15 3.9 44.3 20.5 167.1 DSP US Flexible Equity Fund Growth ₹87.2151
↑ 0.58 ₹1,241 -6.6 -6.4 20.9 23.9 15.8 33.8 SBI Healthcare Opportunities Fund Growth ₹544.341
↑ 5.12 ₹6,067 5.1 16.5 26 23.5 19.7 -3.5 IDBI Diversified Equity Fund Growth ₹37.99
↑ 0.14 ₹382 10.2 13.2 13.5 22.7 12 Invesco India Mid Cap Fund Growth ₹206.1
↑ 2.56 ₹15,831 3 13.3 10.6 22.5 18.2 6.3 UTI Healthcare Fund Growth ₹351.87
↑ 2.71 ₹1,433 3.5 13.4 21.6 22.1 16.7 -3.1 IDBI India Top 100 Equity Fund Growth ₹44.16
↑ 0.05 ₹655 9.2 12.5 15.4 21.9 12.6 Invesco India Growth Opportunities Fund Growth ₹117.34
↑ 1.44 ₹12,438 5.8 18 13.5 21.9 17.1 4.7 IDBI Equity Advantage Fund Growth ₹43.39
↑ 0.04 ₹485 9.7 15.1 16.9 20.8 10 HDFC Long Term Advantage Fund Growth ₹595.168
↑ 0.28 ₹1,318 1.2 15.4 35.5 20.6 17.4 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 19 Nov 26 Research Highlights & Commentary of 10 Funds showcased
Commentary DSP World Gold Fund DSP US Flexible Equity Fund SBI Healthcare Opportunities Fund IDBI Diversified Equity Fund Invesco India Mid Cap Fund UTI Healthcare Fund IDBI India Top 100 Equity Fund Invesco India Growth Opportunities Fund IDBI Equity Advantage Fund HDFC Long Term Advantage Fund Point 1 Upper mid AUM (₹1,442 Cr). Lower mid AUM (₹1,241 Cr). Upper mid AUM (₹6,067 Cr). Bottom quartile AUM (₹382 Cr). Highest AUM (₹15,831 Cr). Upper mid AUM (₹1,433 Cr). Bottom quartile AUM (₹655 Cr). Top quartile AUM (₹12,438 Cr). Bottom quartile AUM (₹485 Cr). Lower mid AUM (₹1,318 Cr). Point 2 Established history (19+ yrs). Established history (14+ yrs). Established history (21+ yrs). Established history (12+ yrs). Established history (19+ yrs). Oldest track record among peers (27 yrs). Established history (14+ yrs). Established history (19+ yrs). Established history (13+ yrs). Established history (25+ yrs). Point 3 Rating: 3★ (upper mid). Top rated. Rating: 2★ (lower mid). Rating: 2★ (bottom quartile). Rating: 2★ (bottom quartile). Rating: 1★ (bottom quartile). Rating: 3★ (upper mid). Rating: 5★ (top quartile). Rating: 3★ (upper mid). Rating: 3★ (lower mid). Point 4 Risk profile: High. Risk profile: High. Risk profile: High. Risk profile: Moderately High. Risk profile: Moderately High. Risk profile: High. Risk profile: Moderately High. Risk profile: Moderately High. Risk profile: Moderately High. Risk profile: Moderately High. Point 5 5Y return: 20.54% (top quartile). 5Y return: 15.82% (lower mid). 5Y return: 19.68% (top quartile). 5Y return: 12.03% (bottom quartile). 5Y return: 18.15% (upper mid). 5Y return: 16.75% (lower mid). 5Y return: 12.61% (bottom quartile). 5Y return: 17.12% (upper mid). 5Y return: 9.97% (bottom quartile). 5Y return: 17.39% (upper mid). Point 6 3Y return: 44.28% (top quartile). 3Y return: 23.94% (top quartile). 3Y return: 23.53% (upper mid). 3Y return: 22.73% (upper mid). 3Y return: 22.48% (upper mid). 3Y return: 22.07% (lower mid). 3Y return: 21.88% (lower mid). 3Y return: 21.88% (bottom quartile). 3Y return: 20.84% (bottom quartile). 3Y return: 20.64% (bottom quartile). Point 7 1Y return: 3.92% (bottom quartile). 1Y return: 20.91% (upper mid). 1Y return: 26.00% (top quartile). 1Y return: 13.54% (lower mid). 1Y return: 10.59% (bottom quartile). 1Y return: 21.60% (upper mid). 1Y return: 15.39% (lower mid). 1Y return: 13.51% (bottom quartile). 1Y return: 16.92% (upper mid). 1Y return: 35.51% (top quartile). Point 8 Alpha: 2.85 (upper mid). Alpha: -5.62 (bottom quartile). Alpha: 3.39 (top quartile). Alpha: -1.07 (bottom quartile). Alpha: 0.00 (bottom quartile). Alpha: 0.06 (lower mid). Alpha: 2.11 (upper mid). Alpha: 9.53 (top quartile). Alpha: 1.78 (upper mid). Alpha: 1.75 (lower mid). Point 9 Sharpe: 0.48 (bottom quartile). Sharpe: 0.79 (upper mid). Sharpe: 0.74 (lower mid). Sharpe: 1.01 (upper mid). Sharpe: -0.16 (bottom quartile). Sharpe: 0.52 (lower mid). Sharpe: 1.09 (upper mid). Sharpe: -0.08 (bottom quartile). Sharpe: 1.21 (top quartile). Sharpe: 2.27 (top quartile). Point 10 Information ratio: -0.67 (bottom quartile). Information ratio: -0.08 (upper mid). Information ratio: 0.08 (upper mid). Information ratio: -0.53 (bottom quartile). Information ratio: 0.00 (upper mid). Information ratio: -0.21 (lower mid). Information ratio: 0.14 (top quartile). Information ratio: 1.22 (top quartile). Information ratio: -1.13 (bottom quartile). Information ratio: -0.15 (lower mid). DSP World Gold Fund
DSP US Flexible Equity Fund
SBI Healthcare Opportunities Fund
IDBI Diversified Equity Fund
Invesco India Mid Cap Fund
UTI Healthcare Fund
IDBI India Top 100 Equity Fund
Invesco India Growth Opportunities Fund
IDBI Equity Advantage Fund
HDFC Long Term Advantage Fund
"The primary investment objective of the Scheme is to seek capital appreciation by investing predominantly in units of MLIIF - WGF. The Scheme may, at the discretion of the Investment Manager, also invest in the units of other similar overseas mutual fund schemes, which may constitute a significant part of its corpus. The Scheme may also invest a certain portion of its corpus in money market securities and/or units of money market/liquid schemes of DSP Merrill Lynch Mutual Fund, in order to meet liquidity requirements from time to time. However, there is no assurance that the investment objective of the Scheme will be realized." Below is the key information for DSP World Gold Fund Returns up to 1 year are on The primary investment objective of the Scheme is to seek capital appreciation by investing predominantly in units of BGF – USFEF. The Scheme may, at the discretion of the Investment Manager also invest in the units of other similar overseas mutual fund schemes, which may constitute a significant part of its corpus. The Scheme may also invest a certain portion of its corpus in money market securities and/or money market/liquid schemes of DSP BlackRock Mutual Fund, in order to meet liquidity requirements from time to time. However, there is no assurance that the investment objective of the Scheme will be realized. It shall be noted ‘similar overseas mutual fund schemes’ shall have investment objective, investment strategy and risk profile/consideration similar to those of BGF – USFEF. Research Highlights for DSP US Flexible Equity Fund Below is the key information for DSP US Flexible Equity Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. Research Highlights for SBI Healthcare Opportunities Fund Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing in a diversified portfolio of Equity and Equity related Instruments across market capitalization. However there can be no assurance that the investment objective under the Scheme will be realized Research Highlights for IDBI Diversified Equity Fund Below is the key information for IDBI Diversified Equity Fund Returns up to 1 year are on The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of mid cap companies. However, there can be no assurance that the funds objectives will be achieved. Research Highlights for Invesco India Mid Cap Fund Below is the key information for Invesco India Mid Cap Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. Research Highlights for UTI Healthcare Fund Below is the key information for UTI Healthcare Fund Returns up to 1 year are on The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing predominantly in Equity and Equity related Instruments of Large Cap companies. However
there can be no assurance that the investment objective under the Scheme will be realized. Research Highlights for IDBI India Top 100 Equity Fund Below is the key information for IDBI India Top 100 Equity Fund Returns up to 1 year are on (Erstwhile Invesco India Growth Fund) The investment objective of the Scheme is to generate long-term capital growth from a diversified portfolio of predominantly equity and equity-related securities. However, there can be no assurance that the objectives of the scheme will be achieved. Research Highlights for Invesco India Growth Opportunities Fund Below is the key information for Invesco India Growth Opportunities Fund Returns up to 1 year are on The Scheme will seek to invest predominantly in a diversified portfolio of equity and equity related instruments with the objective to provide investors with opportunities for capital appreciation and income along with the benefit of income-tax deduction(under section 80C of the Income-tax Act, 1961) on their investments. Investments in this scheme would be subject to a statutory lock-in of 3 years from the date of allotment to be eligible for income-tax benefits under Section 80C. There can be no assurance that the investment objective under the scheme will be realized. Research Highlights for IDBI Equity Advantage Fund Below is the key information for IDBI Equity Advantage Fund Returns up to 1 year are on To generate long term capital appreciation from a portfolio that is predominantly in equity and equity related instruments Research Highlights for HDFC Long Term Advantage Fund Below is the key information for HDFC Long Term Advantage Fund Returns up to 1 year are on 1. DSP World Gold Fund
DSP World Gold Fund
Growth Launch Date 14 Sep 07 NAV (19 Nov 26) ₹47.8163 ↓ -0.93 (-1.91 %) Net Assets (Cr) ₹1,442 on 31 Oct 26 Category Equity - Global AMC DSP BlackRock Invmt Managers Pvt. Ltd. Rating ☆☆☆ Risk High Expense Ratio 1.43 Sharpe Ratio 0.48 Information Ratio -0.67 Alpha Ratio 2.85 Min Investment 1,000 Min SIP Investment 500 Exit Load 0-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 21 ₹10,000 31 Oct 22 ₹7,688 31 Oct 23 ₹9,083 31 Oct 24 ₹12,987 31 Oct 25 ₹24,285 31 Oct 26 ₹29,194 Returns for DSP World Gold Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 Nov 26 Duration Returns 1 Month -15.9% 3 Month -23.6% 6 Month -15% 1 Year 3.9% 3 Year 44.3% 5 Year 20.5% 10 Year 15 Year Since launch 8.5% Historical performance (Yearly) on absolute basis
Year Returns 2025 167.1% 2024 15.9% 2023 7% 2022 -7.7% 2021 -9% 2020 31.4% 2019 35.1% 2018 -10.7% 2017 -4% 2016 52.7% Fund Manager information for DSP World Gold Fund
Name Since Tenure Kaivalya Nadkarni 1 May 25 1.42 Yr. Data below for DSP World Gold Fund as on 31 Oct 26
Equity Sector Allocation
Sector Value Basic Materials 94.33% Asset Allocation
Asset Class Value Cash 3.43% Equity 94.62% Debt 0.01% Other 1.94% Top Securities Holdings / Portfolio
Name Holding Value Quantity BGF World Gold I2
Investment Fund | -68% ₹1,133 Cr 958,135 VanEck Gold Miners ETF
- | GDX29% ₹483 Cr 573,719 Treps / Reverse Repo Investments
CBLO/Reverse Repo | -3% ₹50 Cr Net Receivables/Payables
Net Current Assets | -0% -₹1 Cr 2. DSP US Flexible Equity Fund
DSP US Flexible Equity Fund
Growth Launch Date 3 Aug 12 NAV (19 Nov 26) ₹87.2151 ↑ 0.58 (0.67 %) Net Assets (Cr) ₹1,241 on 31 Oct 26 Category Equity - Global AMC DSP BlackRock Invmt Managers Pvt. Ltd. Rating ☆☆☆☆☆ Risk High Expense Ratio 1.55 Sharpe Ratio 0.79 Information Ratio -0.08 Alpha Ratio -5.62 Min Investment 1,000 Min SIP Investment 500 Exit Load 0-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 21 ₹10,000 31 Oct 22 ₹9,621 31 Oct 23 ₹10,379 31 Oct 24 ₹13,099 31 Oct 25 ₹17,978 31 Oct 26 ₹21,817 Returns for DSP US Flexible Equity Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 Nov 26 Duration Returns 1 Month -5.1% 3 Month -6.6% 6 Month -6.4% 1 Year 20.9% 3 Year 23.9% 5 Year 15.8% 10 Year 15 Year Since launch 16.4% Historical performance (Yearly) on absolute basis
Year Returns 2025 33.8% 2024 17.8% 2023 22% 2022 -5.9% 2021 24.2% 2020 22.6% 2019 27.5% 2018 -1.1% 2017 15.5% 2016 9.8% Fund Manager information for DSP US Flexible Equity Fund
Name Since Tenure Kaivalya Nadkarni 1 May 25 1.42 Yr. Data below for DSP US Flexible Equity Fund as on 31 Oct 26
Equity Sector Allocation
Sector Value Technology 33.48% Industrials 12.59% Financial Services 10.09% Health Care 9.37% Consumer Cyclical 9.32% Communication Services 8.3% Basic Materials 3.86% Consumer Defensive 3.49% Energy 3.25% Utility 1.26% Asset Allocation
Asset Class Value Cash 4.96% Equity 95.03% Debt 0.01% Top Securities Holdings / Portfolio
Name Holding Value Quantity BGF US Flexible Equity I2
Investment Fund | -96% ₹1,233 Cr 1,784,131 Treps / Reverse Repo Investments
CBLO/Reverse Repo | -4% ₹48 Cr Net Receivables/Payables
Net Current Assets | -0% -₹1 Cr 3. SBI Healthcare Opportunities Fund
SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (20 Nov 26) ₹544.341 ↑ 5.12 (0.95 %) Net Assets (Cr) ₹6,067 on 31 Oct 26 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 1.93 Sharpe Ratio 0.74 Information Ratio 0.08 Alpha Ratio 3.39 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 21 ₹10,000 31 Oct 22 ₹10,166 31 Oct 23 ₹12,129 31 Oct 24 ₹19,105 31 Oct 25 ₹19,589 31 Oct 26 ₹22,856 Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 Nov 26 Duration Returns 1 Month 12.9% 3 Month 5.1% 6 Month 16.5% 1 Year 26% 3 Year 23.5% 5 Year 19.7% 10 Year 15 Year Since launch 15.8% Historical performance (Yearly) on absolute basis
Year Returns 2025 -3.5% 2024 42.2% 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 15.35 Yr. Data below for SBI Healthcare Opportunities Fund as on 31 Oct 26
Equity Sector Allocation
Sector Value Health Care 88.34% Basic Materials 7.2% Asset Allocation
Asset Class Value Cash 4.47% Equity 95.53% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA11% ₹654 Cr 3,600,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB8% ₹465 Cr 500,000 Acutaas Chemicals Ltd (Basic Materials)
Equity, Since 30 Jun 24 | 5433495% ₹295 Cr 900,000 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Jan 26 | APOLLOHOSP4% ₹261 Cr 320,000 Torrent Pharmaceuticals Ltd (Healthcare)
Equity, Since 30 Jun 21 | TORNTPHARM4% ₹259 Cr 540,000 Cipla Ltd (Healthcare)
Equity, Since 31 May 26 | 5000874% ₹258 Cr 1,920,000 Laurus Labs Ltd (Healthcare)
Equity, Since 31 Aug 23 | 5402224% ₹238 Cr 1,200,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH4% ₹223 Cr 2,400,000 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Mar 26 | AUROPHARMA3% ₹201 Cr 1,200,000
↓ -118,192 Aster DM Quality Care Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 24 | ASTERDM3% ₹188 Cr 2,700,000 4. IDBI Diversified Equity Fund
IDBI Diversified Equity Fund
Growth Launch Date 28 Mar 14 NAV (28 Jul 23) ₹37.99 ↑ 0.14 (0.37 %) Net Assets (Cr) ₹382 on 30 Jun 23 Category Equity - Multi Cap AMC IDBI Asset Management Limited Rating ☆☆ Risk Moderately High Expense Ratio 2.46 Sharpe Ratio 1.01 Information Ratio -0.53 Alpha Ratio -1.07 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for IDBI Diversified Equity Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 Nov 26 Duration Returns 1 Month 2.4% 3 Month 10.2% 6 Month 13.2% 1 Year 13.5% 3 Year 22.7% 5 Year 12% 10 Year 15 Year Since launch 15.4% Historical performance (Yearly) on absolute basis
Year Returns 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 Fund Manager information for IDBI Diversified Equity Fund
Name Since Tenure Data below for IDBI Diversified Equity Fund as on 30 Jun 23
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 5. Invesco India Mid Cap Fund
Invesco India Mid Cap Fund
Growth Launch Date 19 Apr 07 NAV (20 Nov 26) ₹206.1 ↑ 2.56 (1.26 %) Net Assets (Cr) ₹15,831 on 31 Oct 26 Category Equity - Mid Cap AMC Invesco Asset Management (India) Private Ltd Rating ☆☆ Risk Moderately High Expense Ratio 1.69 Sharpe Ratio -0.16 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 21 ₹10,000 31 Oct 22 ₹10,224 31 Oct 23 ₹11,975 31 Oct 24 ₹18,529 31 Oct 25 ₹21,085 31 Oct 26 ₹20,912 Returns for Invesco India Mid Cap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 Nov 26 Duration Returns 1 Month 11.4% 3 Month 3% 6 Month 13.3% 1 Year 10.6% 3 Year 22.5% 5 Year 18.2% 10 Year 15 Year Since launch 16.7% Historical performance (Yearly) on absolute basis
Year Returns 2025 6.3% 2024 43.1% 2023 34.1% 2022 0.5% 2021 43.1% 2020 24.4% 2019 3.8% 2018 -5.3% 2017 44.3% 2016 1.1% Fund Manager information for Invesco India Mid Cap Fund
Name Since Tenure Aditya Khemani 9 Nov 23 2.9 Yr. Data below for Invesco India Mid Cap Fund as on 31 Oct 26
Equity Sector Allocation
Sector Value Financial Services 25.48% Health Care 24.23% Consumer Cyclical 18.26% Industrials 14.85% Real Estate 9.38% Basic Materials 3.38% Utility 1.83% Technology 1.35% Asset Allocation
Asset Class Value Cash 1.23% Equity 98.77% Top Securities Holdings / Portfolio
Name Holding Value Quantity Prestige Estates Projects Ltd (Real Estate)
Equity, Since 30 Nov 23 | PRESTIGE7% ₹1,154 Cr 7,790,653
↑ 709,125 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | MAXHEALTH7% ₹1,136 Cr 12,218,168
↑ 2,291,941 Meesho Ltd (Consumer Cyclical)
Equity, Since 30 Jun 26 | MEESHO5% ₹853 Cr 37,475,229 The Federal Bank Ltd (Financial Services)
Equity, Since 31 Oct 22 | FEDERALBNK5% ₹846 Cr 26,659,590 Manipal Health Enterprises Ltd (Healthcare)
Equity, Since 31 Jul 26 | MANIPALHOS4% ₹700 Cr 9,878,758 Eternal Ltd (Consumer Cyclical)
Equity, Since 31 Aug 25 | ETERNAL4% ₹651 Cr 20,352,364 Global Health Ltd (Healthcare)
Equity, Since 30 Nov 23 | MEDANTA4% ₹625 Cr 4,577,395 L&T Finance Ltd (Financial Services)
Equity, Since 31 Dec 23 | LTF4% ₹616 Cr 23,237,815
↑ 3,585,524 AU Small Finance Bank Ltd (Financial Services)
Equity, Since 31 Jul 25 | 5406114% ₹600 Cr 5,936,790 IndusInd Bank Ltd (Financial Services)
Equity, Since 31 Jan 26 | INDUSINDBK4% ₹552 Cr 6,129,063 6. UTI Healthcare Fund
UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (20 Nov 26) ₹351.87 ↑ 2.71 (0.78 %) Net Assets (Cr) ₹1,433 on 31 Oct 26 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.26 Sharpe Ratio 0.52 Information Ratio -0.21 Alpha Ratio 0.06 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 21 ₹10,000 31 Oct 22 ₹9,416 31 Oct 23 ₹10,985 31 Oct 24 ₹17,495 31 Oct 25 ₹17,846 31 Oct 26 ₹20,163 Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 Nov 26 Duration Returns 1 Month 11.3% 3 Month 3.5% 6 Month 13.4% 1 Year 21.6% 3 Year 22.1% 5 Year 16.7% 10 Year 15 Year Since launch 15% Historical performance (Yearly) on absolute basis
Year Returns 2025 -3.1% 2024 42.9% 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 4.42 Yr. Data below for UTI Healthcare Fund as on 31 Oct 26
Equity Sector Allocation
Sector Value Health Care 94.12% Asset Allocation
Asset Class Value Cash 5.88% Equity 94.12% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA8% ₹109 Cr 600,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB6% ₹88 Cr 94,707 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY5% ₹75 Cr 607,098
↑ 153,955 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 5323315% ₹69 Cr 190,000 Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLAND4% ₹58 Cr 200,000
↑ 15,000 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 May 21 | ALKEM4% ₹53 Cr 102,500
↑ 13,500 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP3% ₹43 Cr 53,000 Caplin Point Laboratories Ltd (Healthcare)
Equity, Since 31 Dec 23 | CAPLIPOINT3% ₹43 Cr 159,030
↓ -15,789 Global Health Ltd (Healthcare)
Equity, Since 31 Oct 24 | MEDANTA3% ₹42 Cr 310,000
↑ 35,710 Lupin Ltd (Healthcare)
Equity, Since 28 Feb 25 | 5002573% ₹41 Cr 203,834 7. IDBI India Top 100 Equity Fund
IDBI India Top 100 Equity Fund
Growth Launch Date 15 May 12 NAV (28 Jul 23) ₹44.16 ↑ 0.05 (0.11 %) Net Assets (Cr) ₹655 on 30 Jun 23 Category Equity - Large Cap AMC IDBI Asset Management Limited Rating ☆☆☆ Risk Moderately High Expense Ratio 2.47 Sharpe Ratio 1.09 Information Ratio 0.14 Alpha Ratio 2.11 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for IDBI India Top 100 Equity Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 Nov 26 Duration Returns 1 Month 3% 3 Month 9.2% 6 Month 12.5% 1 Year 15.4% 3 Year 21.9% 5 Year 12.6% 10 Year 15 Year Since launch 14.2% Historical performance (Yearly) on absolute basis
Year Returns 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 Fund Manager information for IDBI India Top 100 Equity Fund
Name Since Tenure Data below for IDBI India Top 100 Equity Fund as on 30 Jun 23
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 8. Invesco India Growth Opportunities Fund
Invesco India Growth Opportunities Fund
Growth Launch Date 9 Aug 07 NAV (20 Nov 26) ₹117.34 ↑ 1.44 (1.24 %) Net Assets (Cr) ₹12,438 on 31 Oct 26 Category Equity - Large & Mid Cap AMC Invesco Asset Management (India) Private Ltd Rating ☆☆☆☆☆ Risk Moderately High Expense Ratio 1.71 Sharpe Ratio -0.09 Information Ratio 1.22 Alpha Ratio 9.53 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 21 ₹10,000 31 Oct 22 ₹10,075 31 Oct 23 ₹11,369 31 Oct 24 ₹17,346 31 Oct 25 ₹19,412 31 Oct 26 ₹19,629 Returns for Invesco India Growth Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 Nov 26 Duration Returns 1 Month 13.5% 3 Month 5.8% 6 Month 18% 1 Year 13.5% 3 Year 21.9% 5 Year 17.1% 10 Year 15 Year Since launch 13.6% Historical performance (Yearly) on absolute basis
Year Returns 2025 4.7% 2024 37.5% 2023 31.6% 2022 -0.4% 2021 29.7% 2020 13.3% 2019 10.7% 2018 -0.2% 2017 39.6% 2016 3.3% Fund Manager information for Invesco India Growth Opportunities Fund
Name Since Tenure Aditya Khemani 9 Nov 23 2.9 Yr. Deepak Gupta 1 Oct 26 0 Yr. Data below for Invesco India Growth Opportunities Fund as on 31 Oct 26
Equity Sector Allocation
Sector Value Financial Services 23.25% Health Care 22.26% Industrials 21.32% Consumer Cyclical 18.5% Real Estate 7.73% Basic Materials 2.2% Communication Services 1.78% Energy 1.14% Utility 1.11% Technology 0.38% Asset Allocation
Asset Class Value Cash 0.33% Equity 99.67% Top Securities Holdings / Portfolio
Name Holding Value Quantity InterGlobe Aviation Ltd (Industrials)
Equity, Since 31 Mar 24 | INDIGO8% ₹1,007 Cr 2,020,800
↑ 226,877 Eternal Ltd (Consumer Cyclical)
Equity, Since 30 Jun 23 | ETERNAL8% ₹997 Cr 31,143,612 ICICI Bank Ltd (Financial Services)
Equity, Since 31 Dec 15 | ICICIBANK7% ₹873 Cr 6,607,588
↑ 218,351 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 30 Nov 22 | MAXHEALTH7% ₹813 Cr 8,739,598
↑ 842,682 Sai Life Sciences Ltd (Healthcare)
Equity, Since 31 Dec 24 | SAILIFE5% ₹653 Cr 4,283,799 Prestige Estates Projects Ltd (Real Estate)
Equity, Since 31 Dec 23 | PRESTIGE5% ₹592 Cr 3,992,656
↑ 229,619 ABB India Ltd (Industrials)
Equity, Since 30 Jun 23 | ABB4% ₹509 Cr 751,266 Trent Ltd (Consumer Cyclical)
Equity, Since 28 Feb 22 | 5002513% ₹413 Cr 1,577,268 Aditya Infotech Ltd (Industrials)
Equity, Since 31 Aug 25 | CPPLUS3% ₹395 Cr 1,028,145 The Federal Bank Ltd (Financial Services)
Equity, Since 30 Nov 22 | FEDERALBNK3% ₹349 Cr 10,987,013 9. IDBI Equity Advantage Fund
IDBI Equity Advantage Fund
Growth Launch Date 10 Sep 13 NAV (28 Jul 23) ₹43.39 ↑ 0.04 (0.09 %) Net Assets (Cr) ₹485 on 30 Jun 23 Category Equity - ELSS AMC IDBI Asset Management Limited Rating ☆☆☆ Risk Moderately High Expense Ratio 2.39 Sharpe Ratio 1.21 Information Ratio -1.13 Alpha Ratio 1.78 Min Investment 500 Min SIP Investment 500 Exit Load NIL Growth of 10,000 investment over the years.
Date Value Returns for IDBI Equity Advantage Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 Nov 26 Duration Returns 1 Month 3.1% 3 Month 9.7% 6 Month 15.1% 1 Year 16.9% 3 Year 20.8% 5 Year 10% 10 Year 15 Year Since launch 16% Historical performance (Yearly) on absolute basis
Year Returns 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 Fund Manager information for IDBI Equity Advantage Fund
Name Since Tenure Data below for IDBI Equity Advantage Fund as on 30 Jun 23
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 10. HDFC Long Term Advantage Fund
HDFC Long Term Advantage Fund
Growth Launch Date 2 Jan 01 NAV (14 Jan 22) ₹595.168 ↑ 0.28 (0.05 %) Net Assets (Cr) ₹1,318 on 30 Nov 21 Category Equity - ELSS AMC HDFC Asset Management Company Limited Rating ☆☆☆ Risk Moderately High Expense Ratio 2.25 Sharpe Ratio 2.27 Information Ratio -0.15 Alpha Ratio 1.75 Min Investment 500 Min SIP Investment 500 Exit Load NIL Growth of 10,000 investment over the years.
Date Value
Purchase not allowed Returns for HDFC Long Term Advantage Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 Nov 26 Duration Returns 1 Month 4.4% 3 Month 1.2% 6 Month 15.4% 1 Year 35.5% 3 Year 20.6% 5 Year 17.4% 10 Year 15 Year Since launch 21.4% Historical performance (Yearly) on absolute basis
Year Returns 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 Fund Manager information for HDFC Long Term Advantage Fund
Name Since Tenure Data below for HDFC Long Term Advantage Fund as on 30 Nov 21
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity
Research Highlights for DSP World Gold Fund